Anti-TB APIs
Chemerix Biotech Pvt. Ltd. · IDA Medchal, Hyderabad
| API Name | Capacity / Yr | CAS Number | Therapy | Status |
|---|---|---|---|---|
| Ethambutol HCL | 180 MT | 1070-11-7 | Anti-Tuberculosis | Commercial |
| Clofazimine | 12 MT | 2030-63-9 | Anti-TB / Anti-Leprosy | Commercial |
| Bedaquiline | 24 MT | 843663-66-1 | Anti-Tuberculosis | Under Scale-up |
| Rifampicin | 24 MT | 13292-46-1 | Anti-Tuberculosis | Under Validation |
| Delamanid | 12 MT | 681492-22-8 | Anti-Tuberculosis | Under Validation |
| Rifapentine | 24 MT | 61379-65-5 | Anti-Tuberculosis | Under Validation |
| Rifabutin | 24 MT | 72559-06-9 | Anti-Tuberculosis | In Development |
| Pretomanid | 12 MT | 187235-37-6 | Anti-Tuberculosis | In Development |
API NameEthambutol HCL
Capacity / Yr180 MT
CAS Number1070-11-7
TherapyAnti-Tuberculosis
StatusCommercial
API NameClofazimine
Capacity / Yr12 MT
CAS Number2030-63-9
TherapyAnti-TB / Anti-Leprosy
StatusCommercial
API NameBedaquiline
Capacity / Yr24 MT
CAS Number843663-66-1
TherapyAnti-Tuberculosis
StatusUnder Scale-up
API NameRifampicin
Capacity / Yr24 MT
CAS Number13292-46-1
TherapyAnti-Tuberculosis
StatusUnder Validation
API NameDelamanid
Capacity / Yr12 MT
CAS Number681492-22-8
TherapyAnti-Tuberculosis
StatusUnder Validation
API NameRifapentine
Capacity / Yr24 MT
CAS Number61379-65-5
TherapyAnti-Tuberculosis
StatusUnder Validation
API NameRifabutin
Capacity / Yr24 MT
CAS Number72559-06-9
TherapyAnti-Tuberculosis
StatusIn Development
API NamePretomanid
Capacity / Yr12 MT
CAS Number187235-37-6
TherapyAnti-Tuberculosis
StatusIn Development
Commercial and pipeline status follows the corporate presentation and admin-managed catalog.

